缩写名/全名 |
PROSTATE CANCER P D
PROSTATE CANCER AND PROSTATIC DISEASES |
||||||||||||||||||||||||
ISSN号 | 1365-7852 | ||||||||||||||||||||||||
研究方向 | 医学-泌尿学与肾脏学 | ||||||||||||||||||||||||
影响因子 | 2015:3.803, 2016:3.723, 2017:4.099, 2018:4.6, 2019:4.311, | ||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||
出版周期 | Quarterly | ||||||||||||||||||||||||
年文章数 | 73 | ||||||||||||||||||||||||
出版年份 | 1997 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | http://mts-pcan.nature.com/cgi-bin/main.plex | ||||||||||||||||||||||||
投稿官网 | http://www.nature.com/pcan/index.html | ||||||||||||||||||||||||
h-index | 56 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1365-7852%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis. Author: Zhai L1,2,3,4, Fan Y1,2,5,3,4, Meng Y1,2,3,4, Feng X6, Yu W7,8,9,10, Jin J11,12,13,14. Journal: Prostate Cancer Prostatic Dis. 2019 May;22(2):235-243. doi: 10.1038/s41391-018-0111-4. Epub 2018 Nov 14. PubMed DOI |
2. | Prostate cancer and prostatic diseases Best of China, 2018. Author: Ye DW1,2, Zhu Y3,4. Journal: Prostate Cancer Prostatic Dis. 2019 Mar;22(1):1-2. doi: 10.1038/s41391-018-0117-y. Epub 2018 Dec 5. PubMed DOI |
3. | Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Author: Zhang Y1,2, Yuan P1,2, Ma D3, Gao X1,2, Wei C1,2, Liu Z1,2, Li R1,2, Wang S1,2, Liu J1,2, Liu X4,5. Journal: Prostate Cancer Prostatic Dis. 2019 Feb 28. doi: 10.1038/s41391-019-0135-4. [Epub ahead of print] PubMed DOI |
4. | Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Author: He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Journal: Prostate Cancer Prostatic Dis. 2016 Mar;19(1):7-13. doi: 10.1038/pcan.2015.43. Epub 2015 Sep 22. Review. PubMed |
5. | Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case-control study. Author: Chen X, Hu C, Peng Y, Lu J, Yang NQ, Chen L, Zhang GQ, Tang LK, Dai JC. Journal: Prostate Cancer Prostatic Dis. 2016 Mar;19(1):92-9. doi: 10.1038/pcan.2015.57. Epub 2015 Dec 15. PubMed |
6. | Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis. Author: Zhong S, Yan X, Wu Y, Zhang X, Chen L, Tang J, Zhao J. Journal: Prostate Cancer Prostatic Dis. 2016 Jun;19(2):122-31. doi: 10.1038/pcan.2015.64. Epub 2016 Jan 12. Review. PubMed |
7. | Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy. Author: Wang Y, Yin W, Wang Z, Huang J, Pan J, Zhu Y, Xu F, Shao X, Sha J, Cai Y, Liu Q, Dong B, Xue W, Huang Y. Journal: Prostate Cancer Prostatic Dis. 2016 Jun;19(2):209-15. doi: 10.1038/pcan.2016.6. Epub 2016 Mar 8. PubMed |
8. | Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis. Author: Zhao Y, Lv JJ, Chen J, Jin XB, Wang MW, Su ZH, Wang LY, Zhang HY. Journal: Prostate Cancer Prostatic Dis. 2016 Jul 19. doi: 10.1038/pcan.2016.29. [Epub ahead of print] PubMed |
9. | Body mass index and risk of BPH: a meta-analysis. Author: Wang S, Mao Q, Lin Y, Wu J, Wang X, Zheng X, Xie L. Journal: Prostate Cancer Prostatic Dis. 2012 Sep;15(3):265-72. doi: 10.1038/pcan.2011.65. Epub 2011 Dec 20. PubMed |
10. | MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies. Author: Li XL, Xu JH. Journal: Prostate Cancer Prostatic Dis. 2012 Sep;15(3):244-9. doi: 10.1038/pcan.2012.5. Epub 2012 Feb 28. PubMed |
|
|